Current Metabolomics
Title:Editor’s Perspective: Metabolomics Currently
Volume: 6 Issue: 2
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Editor’s Perspective: Metabolomics Currently, Current Metabolomics 2018; 6 (2) . https://dx.doi.org/10.2174/2213235X0602180716092501
DOI https://dx.doi.org/10.2174/2213235X0602180716092501 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
34
8
Related Articles
-
Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery An Update of In Silico Tools for the Prediction of Pathogenesis in Missense Variants
Current Bioinformatics Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
Current Vascular Pharmacology Natural Medicine:The Genus Angelica
Current Medicinal Chemistry The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications
Current Pharmaceutical Design PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies
Current Pharmaceutical Design Targeting Angiogenesis in Gastro-Intestinal Non Colorectal Cancers; A Review
Current Angiogenesis (Discontinued) Brain Tumor Segmentation Using Deep Belief Networks and Pathological Knowledge
CNS & Neurological Disorders - Drug Targets Research Development of End Traction Shoulder Rehabilitation Device
Recent Patents on Mechanical Engineering Bone Imaging in Metastatic Castration-resistant Prostate Cancer; Where do we Stand
Current Radiopharmaceuticals Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Current Cancer Drug Targets Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Role of Carboxypeptidase N Invasion and Migration in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Heterogeneity Amongst 5-HT3 Receptor Subunits: Is this Significant?
Current Molecular Medicine Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer
Current Women`s Health Reviews Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential
Recent Patents on Inflammation & Allergy Drug Discovery Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
Current Enzyme Inhibition Evaluating the Susceptibility of Mitochondrial DNA Germline Mutations in Chinese Cancer Patients
Current Molecular Medicine RAGE and RAGE Ligands in Cancer
Current Molecular Medicine Mucosal Healing in Ulcerative Colitis: Where do we Stand?
Current Drug Targets